Healthcare provider profile · identity verified

Patricia Rand

Nurse Practitioner · SACO, ME · NPI 1710343777

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Sertraline Hcl	Sertraline Hcl	483	81
Levothyroxine Sodium	Levothyroxine Sodium	422	56
Atorvastatin Calcium	Atorvastatin Calcium	232	39
Amlodipine Besylate	Amlodipine Besylate	217	38
Trazodone Hcl	Trazodone Hcl	205	43
Omeprazole	Omeprazole	173	26
Mirtazapine	Mirtazapine	170	29
Citalopram Hbr	Citalopram Hydrobromide	165	26
Lisinopril	Lisinopril	147	28
Metoprolol Succinate	Metoprolol Succinate	135	24
Donepezil Hcl	Donepezil Hcl	132	27
Risperidone	Risperidone	124	35
Eliquis	Apixaban	108	15
Metoprolol Tartrate	Metoprolol Tartrate	108	22
Methenamine Hippurate	Methenamine Hippurate	101	16
Quetiapine Fumarate	Quetiapine Fumarate	93	15
Memantine Hcl	Memantine Hcl	81	15
Memantine Hcl Er	Memantine Hcl	78	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	78	11
Olanzapine	Olanzapine	74	14
Lorazepam	Lorazepam	71	24
Losartan Potassium	Losartan Potassium	71	13
Warfarin Sodium	Warfarin Sodium	68	suppressed
Pravastatin Sodium	Pravastatin Sodium	62	suppressed
Metformin Hcl	Metformin Hcl	59	12
Escitalopram Oxalate	Escitalopram Oxalate	57	suppressed
Furosemide	Furosemide	56	17
Rosuvastatin Calcium	Rosuvastatin Calcium	55	11
Latanoprost	Latanoprost	54	12
Nystatin	Nystatin	53	26
Famotidine	Famotidine	52	suppressed
Myrbetriq	Mirabegron	51	suppressed
Gabapentin	Gabapentin	50	13
Venlafaxine Hcl Er	Venlafaxine Hcl	50	suppressed
Buspirone Hcl	Buspirone Hcl	48	suppressed
Duloxetine Hcl	Duloxetine Hcl	41	suppressed
Bumetanide	Bumetanide	40	suppressed
Clopidogrel	Clopidogrel Bisulfate	40	suppressed
Lamotrigine	Lamotrigine	40	suppressed
Simvastatin	Simvastatin	38	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	38	suppressed
Glipizide	Glipizide	37	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	37	suppressed
Tramadol Hcl	Tramadol Hcl	37	11
Atenolol	Atenolol	31	suppressed
Rivastigmine	Rivastigmine	30	suppressed
Carvedilol	Carvedilol	25	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	24	23
Carbidopa-Levodopa	Carbidopa/Levodopa	22	suppressed
Estradiol	Estradiol	22	suppressed
Allopurinol	Allopurinol	21	suppressed
Bupropion Hcl	Bupropion Hcl	21	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	21	18
Propranolol Hcl Er	Propranolol Hcl	21	suppressed
Alendronate Sodium	Alendronate Sodium	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Hydrocortisone	Hydrocortisone	18	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	18	suppressed
Jardiance	Empagliflozin	18	suppressed
Oxycodone Hcl	Oxycodone Hcl	18	suppressed
Celecoxib	Celecoxib	17	suppressed
Finasteride	Finasteride	17	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	16	11
Cephalexin	Cephalexin	16	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Folic Acid	Folic Acid	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Timolol Maleate	Timolol Maleate	16	suppressed
Montelukast Sodium	Montelukast Sodium	15	suppressed
Cholestyramine	Cholestyramine (With Sugar)	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Potassium Chloride	Potassium Chloride	13	suppressed
Ramelteon	Ramelteon	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Atropine Sulfate	Atropine Sulfate	12	12
Galantamine Hbr	Galantamine Hbr	12	suppressed
Haloperidol Lactate	Haloperidol Lactate	12	suppressed
Lacosamide	Lacosamide	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Spironolactone	Spironolactone	11	suppressed
Trulicity	Dulaglutide	11	suppressed
Yuvafem	Estradiol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error